Cigna Group Stock Price, News & Analysis

Cigna Healthcare (NYSE: CI) is launching Headspace for Cigna Healthcare, an industry-first collaboration to expand everyday mental health support for millions of members.

Key points: exclusive custom Headspace content for Cigna customers, seamless navigation to in-network clinicians, evidence-backed digital programs reporting 37% anxiety reduction after 8 weeks and 32% depression reduction after 30 days, and planned rollout to more than 7 million people starting Jan 1, 2026 at no cost through employer benefits.

The Cigna Group (NYSE: CI) named Dr. Amy Flaster Chief Medical Officer effective November 1, 2025, expanding her role to lead clinical strategy across Cigna Healthcare and Evernorth. She will focus on clinical excellence, new care models, clinical team growth, and technology to advance whole‑person health, and will report to Brian Evanko.

Katya Andresen, Chief Digital & Analytics Officer, will lead the company’s Excellence & Transformation (XT) initiatives to improve digital, service, and clinical touchpoints. The announcement also notes the departures of Dr. David Brailer (chief health officer) and the retirement of Chris DeRosa after two decades.

The Cigna Group (NYSE: CI) reported third quarter 2025 results: total revenues rose 10% to $69.7 billion and shareholders' net income was $1.9 billion ($6.98 per share). Adjusted income from operations was $2.1 billion ($7.83 per share). The company reaffirmed 2025 adjusted income from operations outlook of at least $29.60 per share.

Segment performance: Evernorth adjusted revenues increased, driven by Pharmacy Benefit Services and Specialty & Care Services; Cigna Healthcare adjusted revenues declined due to the HCSC transaction and a higher medical care ratio. The company announced a new rebate-free pharmacy benefit model and will host a conference call on Oct 30, 2025.

Evernorth (NYSE:CI) unveiled a new rebate-free Express Scripts pharmacy benefit model on Oct 27, 2025 to lower drug costs, improve price transparency, and boost support for local pharmacies.

The plan promises an average 30% reduction in monthly brand-name prescription costs for people who pay full price, automatic selection of the lowest available price at the pharmacy counter, and clinical safeguards including thousands of safety checks. Cigna Healthcare will adopt the model for fully insured lives in 2027; it becomes standard for all Evernorth pharmacy clients in 2028. New pharmacy reimbursement takes effect across in-network pharmacies in 2026.

The Cigna Group (NYSE: CI) declared a quarterly cash dividend of $1.51 per share, payable on December 18, 2025 to shareholders of record as of the close of business on December 4, 2025.

The dividend applies to common stock and specifies the payment and record dates for investor planning.

The Cigna Group Foundation (NYSE: CI) released its Improving Youth Mental Health 2025 Impact Report on October 9, 2025, detailing its first-year youth mental health grant program across 10 states.

The Foundation distributed $3 million in grants to 23 nonprofit partners, reaching over 34,000 youth, families, and professionals through school programs, clinical services, and workshops. Reported activity totals include 8,576 youth education sessions and 4,392 therapy sessions; grantees reported outcome achievement rates up to 94%.

This work is part of a $27 million, three-year investment; a new application period opens in early 2026.

The Cigna Group (NYSE:CI) has scheduled its third quarter 2025 financial results release and conference call for Thursday, October 30, 2025. The financial results will be released by 6:30 a.m. ET, followed by a management conference call at 8:30 a.m. ET.

Participants are encouraged to join the call by 8:15 a.m. ET. The call replay will be available from 12:30 p.m. ET on October 30 until 10:59 p.m. ET on November 13, 2025. A live webcast will be accessible through the company's investor relations website, along with the news release and financial supplement.

The Cigna Group (NYSE:CI), a global health company, announced that its President and COO Brian Evanko and EVP and CFO Ann Dennison will present at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 10, 2025, in New York. The presentation is scheduled to begin at 8:30 a.m. ET.

Investors can access a live webcast of the presentation through The Cigna Group's investor relations website. Interested parties should visit the website at least 15 minutes before the presentation to download any necessary audio software.

AM Best has assigned a "bbb+" (Good) Long-Term Issue Credit Rating to The Cigna Group's (NYSE: CI) new senior unsecured notes totaling $4.5 billion. The debt issuance includes four tranches: $1B at 4.5% due 2030, $1.25B at 4.875% due 2032, $1.5B at 5.25% due 2036, and $750M at 6.0% due 2056.

The proceeds will be used to repay $2 billion of existing term loans and for general corporate purposes. While Cigna's adjusted financial leverage ratio of 43.3% is expected to temporarily increase, AM Best anticipates it will decrease to approximately 40% by 2026. The company maintains strong debt-servicing capabilities with over 6x interest coverage and excellent financial flexibility supported by a $6.5 billion revolving credit agreement.